H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.184 HKD -0.54%
Market Cap: 92.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Huakang Biomedical Holdings Co Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Huakang Biomedical Holdings Co Ltd
Operating Expenses Peer Comparison

Comparables:
K
876
K
1134
1120
O
6929

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Operating Expenses
-ÂĄ22.3m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
K
Kaisa Health Group Holdings Ltd
HKEX:876
Operating Expenses
-HK$132.4m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
K
Kelfred Holdings Ltd
HKEX:1134
Operating Expenses
-HK$70m
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Arts Optical International Holdings Ltd
HKEX:1120
Operating Expenses
-HK$337m
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
-4%
O
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Operating Expenses
-$67.1m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Huakang Biomedical Holdings Co Ltd's Operating Expenses?
Operating Expenses
-22.3m CNY

Based on the financial report for Dec 31, 2023, Huakang Biomedical Holdings Co Ltd's Operating Expenses amounts to -22.3m CNY.

What is Huakang Biomedical Holdings Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-12%

Over the last year, the Operating Expenses growth was -5%.

Back to Top